To continue to hold shares in NOX would be speculating in another biotech company. KZAs shareholders expect them to get experimental drugs to market, not gamble on the performance of other stocks. $2m is a bird in the hand, that will support them in meeting shareholder expectations.
Ann: KZA: Kazia sells stake in Noxopharm, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.91M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 12000 | 1 |
View Market Depth
| Last trade - 16.12pm 17/07/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable